Renal disease as a determinant of increased lipoprotein(a) concentrations in diabetic patients

Diabetes Care

Volumn 22, Issue 12, 1999, Pages 2033-2036

  Boemi, Massimo ^a   Sirolla, Cristina ^a   Fumelli, Paolo ^a   James, Richard W ^b  

^a INRCA   (Italy)

^b UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; PROTEINURIA;

EID: 0033360866     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.12.2033     Document Type: Article

References (38)

1. Kostner GM, Avogaro P, Cazzolato G, Marth E., Bittolo-Bon G, Qunici GB: Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 38:51-61, 1981
2. Armstrong VW, Cremer P, Eberle E, Manke A, Schulze F, Wieland H, Kreuzer H. Seidel D: The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis: dependence on scrum LDL levels. Atherosclerosis 62:249-257, 1986
3. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL: Lp(a) lipoprotein as a risk factor lor myocardial infarction. JAMA 256:2540-2544, 1986
4. Schaefer EJ, Lamon-Fava S, Jenner JL, McNamara JR, Ordovas JM, Davis CE, Abolafia JM, Lippel K, Levy RI: Lipoprotein(a) levels and risk of coronary heart disease in men: the Lipid Research Clinics Coronary Primary Prevention Trial. JAMA 271:999-1003, 1994
5. Bolibar I, Thompson SG, von Eckardstein A, Sandkamp M, Assmann G: Dose-response relationship of serum lipid measurements with the extent of coronary stenosis: strong, independent and comprehensive. Arterioscler Thromb Vasc Biol 15:1035-1042, 1995
6. Bostom AG, Gagnon DR, Cupples LA, Wilson PW, Jenner JL, Ordovas JM, Schaefer EJ, Castelli WP: A prospective investigation of elevated lipoprotein(a) detected by electrophoresis and cardiovascular disease in women: the Framingham Heart Study. Circulation 90:1688-1695, 1994
7. Heesen BJ, Wolfenbuttel BH, Leurs PB, Sels JP, Menheere PP, Jackle-Beckers SE, Nieuwenhuijzen Kruseman AC: Lipoprolein(a) levels in relation to diabetic complications in patients with non-insulin dependent diabetes. Eur J Clin Invest 23: 580-584, 1993
8. Ruiz J, Thillet J, Huby T, James RW, Erlich D, Flandre P, Froguel P, Chapman J, Passa P: Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients: relationship with apolipoprotein(a) phenotypes. Diabetologia 37:585-591, 1994
9. James RW, Boemi M, Sirolla C, Amadio L, Fumelli P, Pometta D: Lipoprotein(a) and vascular disease in diabetic patients. Diabetologia 38:711-714, 1995
10. Hirata K, Saku K, Jimi S, Kikuchi S, Hamaguchi H, Arakawa K: Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients. Diabetologia 38:1434-1442, 1945
11. Haffner S: Lipoprotein(a) and diabetes. Diabetes Care 16:835-840, 1943
12. Jenkins AJ. Best JD: The role of lipoprotein(a) in the vascular complications of diabetes. J Intern Med 237:359-365, 1995
13. Kronenberg E, Utermann G, Dieplinger H: Lipoprotein(a) in renal disease. Am J Kidney Dis 27:1-25, 1996
14. Mooser V, Seabra MC, Abedin M, Landschulz KT, Marcovina S, Hobbs HH: Apolipoprotein(a) kringle 4-containing fragments in human urine: relationship to plasma levels of lipoprotein(a). J Clin Invest 97:858-864, 1996
15. Clodi M, Oberbauer R, Waldhäusl W, Maurer G, Kostner GM, Kostner K: Urinary excretion of apo(a) fragments in NIDDM patients. Diabetologia 40:1455-1460, 1997
16. Jenkins AJ, Steele JS, Janus ED, Best JD: Increased plasma apolipoprotein(a) levels in IDDM patients with microalbuminuria. Diabetes 40:787-790, 1991
17. Winocour PH, Bhatnagar D, Ishola M, Arrol S, Durrington PN: Lipoprotein(a) and microvascular disease in type 1 (insulin-dependent) diabetes. Diabet Med 8:922-927, 1991
18. Csaszar A, Dieplinger H, Sandholzer C, Karadi I, Juhasz E, Drexel H, Halmos T, Romics L, Patsch JR, Utermann G: Plasma lipoprotein(a) concentration and phenotypes in diabetes mellitus. Diabetologia 36:47-51, 1993
19. James RW, Pometta D: Differences in lipoprotein subfraction composition and distribution between type 1 diabetic men and control subjects. Diabetes 39:1158-1164, 1990
20. James RW, Pometta D: The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34:246-252, 1991
21. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-501, 1972
22. Appel G, Blum B, Chen S, Kunis C, Appel A: The hyperlipidemia of the nephrotic syndrome: relation to plasma albumin concentration, oncotic pressure and viscosity. N Engl J Med 312:1544-1548, 1985
23. Heller FR, Jamart J, Honore P. Derue G, Novik V, Galanti L, Parfonry A, Hondekijn JC, Buysschaert M: Scrum lipoprotein(a) in patients with diabetes mellitus. Diabetes Care 16:819-823, 1993
24. Durlach V, Gillery P, Berlin E, Taupin JM, Grulet H, Gross A, Leutenegger M: Serum lipoprotein(a) concentrations in a population of 819 non-insulin-dependent diabetic patients. Diabete Metab 22:319-322, 1996
25. Irish AB, Simons LA, Simons J: Lipoprotein(a) concentrations in diabetes: relationship to proteinuria and diabetes control. Aust NZ J Med 22:329-333, 1992
26. Haffner SM, Moss SE, Klein BE, Klein R: Lack of association between lipoprotein(a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Metabolism 41:194-197, 1992
27. Nielsen FS, Voldsgaard AI, Gall M-A, Rossing P, Hommel E, Andersen P, Dyerberg J, Parving HH: Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy. Diabetologia 36:438-444, 1993
28. Maser RE, Usher D, Becker DJ, Drash AL, Kuller LH, Orchard TJ: Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort. Diabetes Care 16:755-758, 1993
29. Ritter MM, Loscar M, Richter WO, Schwandt P: Lipoprotein(a) in diabetes mellitus. Clin Chim Acta 214:45-54, 1993
30. Westerhuis LW, Venekamp WJ: Serum lipoproteina levels and glyco-metabolic control in insulin and non-insulin dependent diabetes mellitus. Clin Biochem 29: 255-259, 1996
31. lc and subclinical complications. Eur J Pediatr 155:175-178, 1996
32. Takegoshi T, Haba T, Hirai J, Kitoh C, Saga T, Yamazaki Y, Mabuchi H: Alterations of lipoprotein(a) in patients with diabetic nephropathy. Atherosclerosis 83:99-100, 1990
33. Jenkins AJ, Steele JS, Janus ED, Santamaria JD, Best JD: Plasma apolipoprotein(a) is increased in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 35:1055-1059, 1992
34. Hernandez C. Simo R, Chacon P, Segarra A, Lopez D, Mesa J: Relationship between lipoprotein(a) phenotypes and albumin excretion rate in non-insulin dependent diabetes mellitus: protective effect of the "null" phenotype. Eur J Clin Invest 27:497-502, 1997
35. Groop PH, Viberti GC, Elliot TG, Friedman R, Mackie A, Ehnholm C, Jauhiainen M, Taskinen MR: Lipoprotein(a) in type 1 diabetic patients with renal disease. Diabet Med 11:961-967, 1994
36. Tarnow L, Rossing P, Nielsen FS, Hansen Bv, Dyerberg J, Parving HH: Increased plasma apolipoprotein(a) levels in IDDM patients with diabetic nephropathy. Diabetes Care 19:1382-1387, 1996
37. Gazzaruso C, Garzaniti A, Buscaglia P, D'Annunzio G, Porta A, Vandelli G, Lorini R, Finardi G, Fratino R Geroldi D: Lipoprotein(a) levels and apolipoprotein(a) polymorphism in type 1 diabetes mellitus: relationships to microvascular and neurological complications. Acta Diabetologia 35: 13-18, 1998
38. Clodi M, Oberbauer R, Bodlaj G, Hofmann J, Maurer G, Kostner K: Urinary excretion of apolipoprotein(a) fragments in type 1 diabetes mellitus patients. Metabolism 48: 369-372, 1999